Equillium, Inc.

NasdaqCM:EQ Stock Report

Market Cap: US$33.5m

Equillium Management

Management criteria checks 3/4

Equillium's CEO is Bruce Steel, appointed in Jan 2006, has a tenure of 19.08 years. total yearly compensation is $1.35M, comprised of 33.8% salary and 66.2% bonuses, including company stock and options. directly owns 10.48% of the company’s shares, worth $3.51M. The average tenure of the management team and the board of directors is 7 years and 6.4 years respectively.

Key information

Bruce Steel

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage33.8%
CEO tenure19.1yrs
CEO ownership10.5%
Management average tenure7yrs
Board average tenure6.4yrs

Recent management updates

Recent updates

Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Nov 16
Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Sep 26
Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

Jun 16
Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

May 01
We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Mar 27
Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Aug 14
Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Aug 12
Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

May 03
Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Mar 26
Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Equillium GAAP EPS of -$0.41 in-line

Aug 15

Equillium CEO Bruce Steel - Drugs For Autoimmune, Inflammatory Disorders (Video)

Oct 08

Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

Mar 09
Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

Equillium prices $30M registered direct offering

Feb 04

Equillium (EQ) Investor Presentation - Slideshow

Dec 04

How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

Nov 24
How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

FDA gives green signal to Equillium's late-stage COVID-19 trial

Oct 30

CEO Compensation Analysis

How has Bruce Steel's remuneration changed compared to Equillium's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$12m

Dec 31 2023US$1mUS$455k

-US$13m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$2mUS$455k

-US$62m

Sep 30 2022n/an/a

-US$76m

Jun 30 2022n/an/a

-US$72m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$2mUS$440k

-US$39m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$31m

Dec 31 2020US$782kUS$198k

-US$30m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$1mUS$396k

-US$26m

Sep 30 2019n/an/a

-US$23m

Jun 30 2019n/an/a

-US$22m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$452kUS$219k

-US$13m

Compensation vs Market: Bruce's total compensation ($USD1.35M) is above average for companies of similar size in the US market ($USD638.32K).

Compensation vs Earnings: Bruce's compensation has been consistent with company performance over the past year.

CEO

Bruce Steel (58 yo)

19.1yrs

Tenure

US$1,348,215

Compensation

Mr. Bruce D. Steel, CFA has been Chief Executive Officer of Equillium, Inc. since January 1, 2020. He has been a Managing Director at BioMed Ventures LP since September 2010. Mr. Steel serves as President...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Bradbury
Executive Chairman7.9yrsUS$267.30k5.29%
$ 1.8m
Bruce Steel
Co-Founder19.1yrsUS$1.35m10.48%
$ 3.5m
Christine Zedelmayer
Senior VP & COO7yrsUS$785.51k0.38%
$ 127.7k
Stephen Connelly
Chief Scientific Officer & Director7.1yrsUS$827.25k2.8%
$ 937.8k
Jason Keyes
Chief Financial Officer6.9yrsno data0.36%
$ 119.6k
Penny Tom
Senior VP of Finance & Principal Accounting Officerno datano data0.018%
$ 6.2k
Michael Moore
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Matthew Ritter
Senior Vice President of Corporate Development4.8yrsno datano data
Joel Rothman
Chief Development Officer5.2yrsno data0.16%
$ 54.9k

7.0yrs

Average Tenure

54.5yo

Average Age

Experienced Management: EQ's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Daniel Bradbury
Executive Chairman7.9yrsUS$267.30k5.29%
$ 1.8m
Bruce Steel
Co-Founder7.9yrsUS$1.35m10.48%
$ 3.5m
Stephen Connelly
Chief Scientific Officer & Director7.9yrsUS$827.25k2.8%
$ 937.8k
Martha Demski
Independent Director6.4yrsUS$98.77k0.067%
$ 22.5k
Bala Manian
Independent Director7.8yrsUS$101.79k0.067%
$ 22.5k
Thomas Daniel
Member of Scientific & Clinical Advisory Board5.8yrsno datano data
Mark Pruzanski
Independent Director6.4yrsUS$83.77k0.067%
$ 22.5k
Vijay Kuchroo
Member of Scientific & Clinical Advisory Boardno datano datano data
Peter Colabuono
Directorless than a yearno datano data
Barbara Troupin
Independent Director3yrsUS$65.25k0%
$ 0
Charles McDermott
Independent Director6.4yrsUS$60.69k0.067%
$ 22.5k
Fred Ramsdell
Member of Scientific & Clinical Advisory Boardno datano datano data

6.4yrs

Average Tenure

63yo

Average Age

Experienced Board: EQ's board of directors are considered experienced (6.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 13:49
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Equillium, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lut Ming ChengCantor Fitzgerald & Co.
Raghuram SelvarajuH.C. Wainwright & Co.
Biren AminJefferies LLC